EquiReason
ClaimedAn entire research department running as software
From $49/mo, billed monthly (free plan available) Visit WebsiteTracked since 2026
The Bottom Line
- Best for
- Self-directed investors, independent analysts and small teams who research US stocks without a research department of their own.
- Price
- From $49/mo, billed monthly (free plan available). Compare plans
Key facts
- Covers about 3,100 US-listed companies from their SEC filings.
- Each verdict carries the evidence for and against it, tied to the filing it came from.
- Prices are delayed 15 minutes; it is a research tool, not investment advice.
Pros
- Every conclusion links back to the SEC filing it came from, so a number can be checked rather than taken on trust
- Exposure to a trend is checked against reported segment or product revenue; where a company does not disclose it, the link is labelled as a proxy
- The underlying data is open: you can read the filed record of any covered company before paying anything
Cons
- US-listed companies only (about 3,100); no international exchanges yet
- Prices are delayed 15 minutes; it is a research tool, not a trading terminal
- New product: no third-party reviews yet
What is EquiReason?
EquiReason is an entire research department running as software: it reads every SEC filing, traces what is changing in the world to the companies it actually reaches, and holds a verdict on each, with the evidence for and against it. The data underneath is open without an account: financial statements for every year on file, 8-K events, Form 4 insider trades and 13F holders for about 3,100 US companies.
Available on: Web, iOS
Data compiled by Toolradar Pricing checked · How we evaluate
Source equireason.com Preview
Key Features
- Trend board: what is changing in the world and which companies it actually reaches
- Company verdicts with the evidence for and against, tied to SEC filings
- Alerts when a verdict, guidance, insider buying or 13F holders change
- Open filed record: financial statements for every year on file, 8-K events, insider trades and 13F holders, free without an account
Pricing Plans
7-day Free TrialPricing checked Oct 26, 2026. Source: equireason.com/pricing, read Oct 26, 2026
| Plan | Price | Details |
|---|---|---|
| Free | $0 |
|
| Analyst | $49 / mo |
+1 more Show less
|
| Research Pro | $89 / mo |
+2 more Show less
|
| Teams & Data | Contact us |
+2 more Show less
|
Is EquiReason worth the price?
Good value
EquiReason's pricing is fair and competitive for the depth of research automation it offers, with the $49/mo Analyst tier delivering strong value for individual investors and the $89/mo Research Pro tier justifying its premium with market-wide screens and unlimited alerts.
The free tier is generous for basic monitoring, but the Teams & Data tier's contact-us pricing is typical for enterprise deals. It's best for serious retail investors and small research teams who want institutional-grade equity analysis without hiring analysts.
Reviews
$99 Free with your review
Write a review Review EquiReason, get a free AI guide
Share your experience and we will send you Improve Your Thinking Patterns Using ChatGPT, free.
Explore More
EquiReason FAQ
Is there a free trial?
Yes. Research Pro has a seven-day trial that takes no card. When the seven days end you drop to Free automatically, so nothing is charged and there is nothing to cancel.
Do cheaper plans see fewer companies?
No. Every plan can search, open and list every company we cover, with no index restriction. Plans differ by how deep the evidence goes, not by which companies you are allowed to look at.
Where does the data come from?
Company filings from SEC EDGAR (annual, quarterly and current reports, XBRL financial facts, institutional 13F holdings and Form 4 insider transactions), plus earnings-call language, and market and analyst data from licensed providers. Every layer states its source and freshness, and missing evidence is shown rather than hidden.
Is there a mobile app?
Yes. The iPhone app uses the same account, so the plan you buy on the web works there too.
Is this investment advice?
No. EquiReason is a research tool. It shows the evidence, the reasoning and the limits of both, so you can reach your own conclusion. It does not tell you what to do with your money, and we are not licensed advisers.
Source: equireason.com